Malignant Hyperthermia by Vasnaik, Ashley Casimir
Otterbein University 
Digital Commons @ Otterbein 
Nursing Student Class Projects (Formerly MSN) Student Research & Creative Work 
7-25-2018 
Malignant Hyperthermia 
Ashley Casimir Vasnaik 
Otterbein University, ashley.vasnaik@otterbein.edu 
Follow this and additional works at: https://digitalcommons.otterbein.edu/stu_msn 
 Part of the Nursing Commons 
Recommended Citation 
Vasnaik, Ashley Casimir, "Malignant Hyperthermia" (2018). Nursing Student Class Projects (Formerly 
MSN). 335. 
https://digitalcommons.otterbein.edu/stu_msn/335 
This Project is brought to you for free and open access by the Student Research & Creative Work at Digital 
Commons @ Otterbein. It has been accepted for inclusion in Nursing Student Class Projects (Formerly MSN) by an 
authorized administrator of Digital Commons @ Otterbein. For more information, please contact 
digitalcommons07@otterbein.edu. 
Malignant Hyperthermia 
Ashley Casimir Vasnaik, SRNA, BSN, RN, CCRN
Introduction Significance Of Pathophysiology
References
Signs and Symptoms
Otterbein University, Westerville, Ohio









To	understand	the	pathophysiology	of	MH,	one	must	first	understand	the	normal	physiology	of	muscle	contraction.	In	normal	muscle	physiology,	an	action	potential	causes	membrane	depolarization	which	releases	calcium	(Ca2+)	from	the	sarcoplasmic	reticulum	(SR).	The	Ca2+ is	thus	inserted	into	the	sarcoplasm	via	the	ryanodine	and	dihydropyridine	receptors.	Both	of	these	receptors	are	voltage-gated	ion	channels.	The	Ca2+ then	interacts	with	the	troponin-tropomyosin	complex	which	creates	the	cross-bridge	between	actin	and	myosin	and	a	muscle	contraction	occurs.	At	the	completion	of	the	muscle	contraction,	Ca2+ is	sequestered	back	into	the	sarcoplasmic	reticulum	and	the	another	stimulus	is	needed	to	release	Ca2+ for	a	muscle	contraction	(Schneiderbanger et	al.,	2014).
Underlying 
PathophysiologyIn	MH,	the	mutated	RYR1 gene	receptor	threshold	is	decreased	for	Ca2+release.	The	RYR1 receptors	are	also	resistant	to	the	negative	feedback	loop	(increase	Ca2+ and	magnesium)	that	would	normally	decrease	the	Ca2+conductance.This	equates	to	an	overt	release	of	Ca2+,	in	response	to	lower	levels	of	membrane	depolarization.	This	causes	an	increased	amount	of	Ca2+ to	be	present	in	the	sarcoplasm	which	causes	continuous	and	prolonged	muscle	contractions	when	attached	to	the	troponin-tropomyosin	complex.	Adenosine	triphosphate	(ATP)	is	consumed	in	every	step	of	intracellular	Ca2+ interactions.	These	steps	include:- Decoupling	of	Ca2+ from	troponin- Removal	of	intracellular	Ca2+- Returning (Ca2+)	to	the	SR	and	mitochondria- Extrusion	into	the	extracellular	milieu(Hines	&	Marschall,	2012).	Oxygen	and	glycogen	are	thus	used	in	massive	quantities	by	the	mitochondria	as	the	body	attempts	to	create	more	ATP	in	response	to	the	highly	increased	metabolic	demands.	The	metabolic	byproducts	of	this	process	are	carbon	dioxide	and	lactate.	In	addition,	the	body	produces	massive	amounts	of	heat	as	the	ATP	is	used	by	muscles	for	contraction.	
Long	&	Ross	(2017)	stated	that	if	MH	is	not	treated,	the	body’s	innate	ability	to	maintain	homeostasis	is	overwhelmed	and	this	can	lead	to	cardiovascular	collapse	and	eventually	death.	Therefore,	prompt	recognition	and	intervention	is	necessary	to	prevent	irreversible	damage.	Hirchey Dirksen	et	al.,	(2013)	stated	that	the	MH	response	leads	to	a	variety	of	internal	reactions	secondary	to	the	disruption	of	cell	membranes	such	as	an	increase	in	serum	potassium,	phosphate,	magnesium,	and	myoglobin	in	the	extracellular	fluid.	Furthermore,	the	complications	that	can	occur	include	permanent	skeletal	muscle	damage,	hyperthermia	(core	temperatures	between	39℃ &	41℃),	renal	failure	(secondary	to	rhabdomyolysis),	cardiac	arrest,	and	possible	death.		Some	of	the	short	and	long	term	complications	of	MH	are	rhabdomyolysis	with	an	accompanying	compartment	syndrome,	disseminated	intravascular	coagulation	(DIC),	heart	failure,	pulmonary	edema,	cerebral	edema	with	or	without	herniation,	acute	liver	failure,	shock	secondary	to	a	mixed	metabolic	and	respiratory	acidosis,	bowel	ischemia,	other	end	multi	organ	failure,	cardiac	collapse,	and	eventually	death	(Epocrates:	An	Athenahealth Service,	2018).	
Schneiderbanger et	al.,	(2014)	stated	that	the	severity	of	a	MH	crisis	depends	on	how	quickly	the	disease	process	is	suspected	and	how	rapidly	an	appropriate	treatment	is	initiated.	Once	MH	has	been	recognized,	it	is	imperative	to	discontinue	the	offending	triggering	agent.	Anesthesia	should	immediately	be	converted	to	total	intravenous	anesthesia	(TIVA)	with	the	use	of	IV	opioids,	sedatives,	and	if	the	patient	status	necessitates	it,	a	non	depolarizing	muscle	relaxant.	The	vaporizer	that	was	used	for	administration	of	the	volatile	anesthetic	should	be	removed	and	the	patient	hyperventilated	with	100%	oxygen	at	maximum	fresh	gas	flow	while	an	activated	charcoal	filter	is	placed.	There	must	also	be	an	increase	in	the	minute	volume	by	2x	– 3x	times	the	patient’s	baseline	in	an	attempt	to	flush	the	volatile	anesthetic	from	the	patients	system	while	also	aiming	to	decrease	the	end-tidal	CO2	to	within	normal	limits.		Hirchey Dirksen	et	al.,	(2013)	states	that	the	main	medication	that	should	be	used	in	a	MH	crisis	is	dantrolene	sodium	at	2.5	mg/kg	IV	every	5-10	minutes	based	on	actual	body	weight.	Long	&	Ross	(2017)	state	that	this	medication	interferes	with	the	release	of	Ca2+from	the	SR	which	results	in	a	decrease	in	the	Ca2+ in	the	myoplasm.	This	is	because	dantrolene	is	a	specific	ryanodine	receptor	antagonist.	It	is	recommended	that	36	vials	of	dantrolene	be	stocked	at	any	facility	where	the	causative	agents	of	MH	are	used	to	treat	a	patient	in	MH	crisis	as	they	will	require	a	very	large	quantity	of	dantrolene.	Once	a	MH	crisis	has	been	confirmed,	and	the	administration	of	dantrolene	has	begun,	other	supportive	measures	must	be	started.	Hirchey Dirksen	et	al.,	(2013)	states	to	administer	sodium	bicarbonate	to	correct	the	acid-base	balance	secondary	to	the	mixed	respiratory	and	metabolic	acidosis.	








ContinuedThyrotoxocosisPheochromocytomaMetastatic	carcinoidDrug	induced	muscle	injuryMDMA	overdose	Use	of	designed	drugs	of	newpsychoactive	substances	Alpha	PVP	or	“Flakka”Exertional	heat	strokeThermal	dysregulationIatrogenic	overheatingMeperidine/MAOI	overdoseCocaine	intoxification(Epocrates:	An	Athenahealth Service,	2018).	According	to	Rosenberg	et	al.,	(2015),	patients	with	Central	Core	Disease,	(CCD),	Multi-minicore Disease	(MmD),	central	nuclear	myopathy,	and	King-Denborough syndrome	are	predisposed	to	episodes	of	MH.	
